TokenPost topic

Rhythm Pharmaceuticals

1 TokenPost story is tagged Rhythm Pharmaceuticals. The newest appear first.

Latest Rhythm Pharmaceuticals stories

• Rhythm Pharmaceuticals Expects to Dose First Phase III Patients in January

  The company committed $350 million to a royalty buy-down. CEO David Meeker cited $92 million in third-quarter revenue and called the U.S. launch an “excellent start.”

  Nov 3, 2026, 11:02 PM EST · Business